Provided by Tiger Trade Technology Pte. Ltd.

SPYRE THERAPEUTICS INC

88.50
-0.8300-0.93%
Post-market: 88.500.00000.00%19:30 EDT
Volume:1.43M
Turnover:125.20M
Market Cap:7.80B
PE:-44.03
High:90.00
Open:87.06
Low:85.00
Close:89.33
52wk High:110.18
52wk Low:14.51
Shares:88.17M
Float Shares:80.98M
Volume Ratio:0.85
T/O Rate:1.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0100
EPS(LYR):-1.9755
ROE:-22.98%
ROA:-19.81%
PB:8.17
PE(LYR):-44.80

Loading ...

Aug 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 17, 2025

Major Issues Report

Form 8-K - Current report
Jun 02, 2025

Major Issues Report

Form 8-K - Current report
May 22, 2025

Correspondence

Form CORRESP - Correspondence
May 09, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 07, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Correspondence

Form CORRESP - Correspondence
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Nov 18, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Nov 18, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Nov 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]